Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer

Inclusion Criteria

• •Cytohistological diagnosis of ductal pancreatic adenocarcinoma .
• •Stage III disease (see above).
• •The patient is not a candidate for continued chemotherapy or (chemo)radiotherapy due to lack of demonstrable efficiency or to the side effects of the drugs.
• •Age between 18 and 80 years.
• •Anticipated compliance with treatment and follow-up.
• •Double informed consent for both imILT and possible surgery with radical intent (in the event of pre-operative overstaging).
• •At least a part of the tumor can be treated with imILT without damage to surrounding vital structures.
• •Have an ECOG performance status \< 1 (l'Eastern Cooperative Oncology Group)